EXOME

all the information, none of the junk | biotech • healthcare • life sciences

Matthew Ottmer Joins Voyager Tx as Chief Operating Officer

Xconomy Boston — 

Voyager Therapeutics (NASDAQ: VYGR) has named Matthew Ottmer chief operating officer. Cambridge, MA-based Voyager is developing treatments for neurological diseases. Ottmer comes to the company from another Cambridge biotech, Momenta Pharmaceuticals (NASDAQ: MNTA), where he was chief operating officer.